Photo : © GSK
We must move beyond seeing drug administration as just a simple task , and instead , one that is complex with many nuances , depending on the patient ’ s needs and requirements .
“ A drug is not just a drug . There is this whole ecosystem around it - the schedule , how it ' s administered correctly and so forth . This is a great opportunity for ML and AI ,” explains Agapow .
“ How can we use the software as a medical device to increase the accuracy of administering drugs ? So , using software ML models to diagnose people and monitor how they are doing following a course of treatment so we can intervene at the right time – we can prioritise patients .”
Challenges surrounding AI regulation The increased application of AI within the healthcare industry – and more specifically , drug development – will depend heavily on laws surrounding regulations . AI-related risk mitigation
mobile-magazine . com 123